Profusa, Inc. Common Stock (PFSA)

Profusa, Inc. announced that it has received a notice from Nasdaq confirming its compliance with the Nasdaq Listing Rule 5550(a)(4) regarding publicly held shares. The company initially fell below the 500,000 publicly held shares requirement after a 1-for-4 reverse stock split but has since rectified the situation. This compliance has no effect on the listing or trading of Profusa's securities on The Nasdaq Capital Market under the symbol "PFSA."

Profusa, Inc. is calling a virtual special meeting on September 18, 2026, to seek stockholder approval for its board to implement one or more reverse stock splits on its common stock by September 18, 2028. If approved, the board will have complete discretion over the timing and execution of any reverse split without further stockholder votes. The company has already completed a reverse stock split on August 17, 2026, with related data retroactively adjusted.

HRT Financial LP has reduced its stake in Profusa Inc (PFSA) by 3,163 shares, selling them at $3.5992 per share. This move leaves HRT Financial LP with 71,035 shares, representing 28.41% of its holdings in Profusa, and comes amid severe deterioration in Profusa's financial health, marked by deep losses, negative growth metrics, and a low GF Score of 8/100. The reduction signals caution from the investment firm, reflecting broader concerns about Profusa's long-term viability and highlighting the risks of investing in early-stage medical technology companies with unproven revenue streams.

Profusa has amended its securities purchase agreement with Ascent Partners Fund, resetting the warrant exercise price and debt conversion price to $1.07 per share. The company also issued a Senior Secured Convertible Promissory Note for $714,286 principal, carrying a 7% interest rate and maturing in August 2027. This adjustment allows for potential equity payments for interest and sets a floor price for conversion.

Profusa has secured $714,285.72 through a new senior secured convertible note with Ascent Partners Fund, bearing 7% interest and maturing in August 2027. Additionally, Profusa plans to convert $6.14 million of existing debt, including accrued interest, into Series A Non-Voting Convertible Preferred Stock with Ascent. These actions aim to reduce debt and simplify the company's capital structure.